These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets. Haq SA; Tournadre A Int J Rheum Dis; 2015 Nov; 18(8):818-25. PubMed ID: 26385431 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapies for Immune-Mediated Myopathies: A Current Perspective. Needham M; Mastaglia FL Neurotherapeutics; 2016 Jan; 13(1):132-46. PubMed ID: 26586486 [TBL] [Abstract][Full Text] [Related]
4. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations. Ernste FC; Reed AM Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022 [TBL] [Abstract][Full Text] [Related]
5. [Biological therapy in idiopathic inflammatory myopathies]. Bodoki L; Nagy-Vincze M; Griger Z; Péter A; András C; Dankó K Orv Hetil; 2014 Jan; 155(1):3-10. PubMed ID: 24379090 [TBL] [Abstract][Full Text] [Related]
6. Biologic therapy in the idiopathic inflammatory myopathies. Khoo T; Limaye V Rheumatol Int; 2020 Feb; 40(2):191-205. PubMed ID: 31680207 [TBL] [Abstract][Full Text] [Related]
7. Clinical Evaluation and Management of Inflammatory Myopathies. Chhibber S; Amato AA Semin Neurol; 2015 Aug; 35(4):347-59. PubMed ID: 26502759 [TBL] [Abstract][Full Text] [Related]
12. Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies. Mageriu V; Manole E; Bastian AE; Staniceanu F J Immunol Res; 2020; 2020():9079083. PubMed ID: 32775472 [TBL] [Abstract][Full Text] [Related]